Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Validation of a new integrated prognostic score to predict non-relapse mortality in patients undergoing reduced-intensity conditioning allogeneic hematopoietic cell transplantation.

× No keyword cloud information.

13 in total

1. Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation score allows a better stratification of high-risk patients undergoing reduced-toxicity allogeneic hematopoietic cell transplantation.

Authors: Pere Barba; Rodrigo Martino; José Antonio Pérez-Simón; Francesc Fernández-Avilés; Nerea Castillo; José Luis Piñana; Lucía López-Anglada; Montserrat Rovira; Francesc Bosch; Enric Carreras; Lucía López Corral; Jorge Sierra; David Valcárcel
Journal: Biol Blood Marrow Transplant Date: 2013-10-17 Impact factor: 5.742

2. How I assess comorbidities before hematopoietic cell transplantation.

Authors: Mohamed L Sorror
Journal: Blood Date: 2013-01-25 Impact factor: 22.113

Review 3. Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation.

Authors: Simona Iacobelli
Journal: Bone Marrow Transplant Date: 2013-03 Impact factor: 5.483

4. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors: Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal: Blood Date: 2005-06-30 Impact factor: 22.113

5. "To combine or not to combine": optimizing risk assessment before allogeneic hematopoietic cell transplantation.

Authors: Mahmoud ElSawy; Barry E Storer; Mohamed L Sorror
Journal: Biol Blood Marrow Transplant Date: 2014-05-09 Impact factor: 5.742

6. Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience.

Authors: J L Piñana; R Martino; P Barba; N Margall; M C Roig; D Valcárcel; J Sierra; N Rabella
Journal: Bone Marrow Transplant Date: 2009-08-10 Impact factor: 5.483

7. Regression modelling strategies for improved prognostic prediction.

Authors: F E Harrell; K L Lee; R M Califf; D B Pryor; R A Rosati
Journal: Stat Med Date: 1984 Apr-Jun Impact factor: 2.373

8. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Authors: A Gratwohl; J Hermans; J M Goldman; W Arcese; E Carreras; A Devergie; F Frassoni; G Gahrton; H J Kolb; D Niederwieser; T Ruutu; J P Vernant; T de Witte; J Apperley
Journal: Lancet Date: 1998-10-03 Impact factor: 79.321

9. Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem cell transplantation with AML in first complete remission.

Authors: J Versluis; M Labopin; D Niederwieser; G Socie; R F Schlenk; N Milpied; A Nagler; D Blaise; V Rocha; J J Cornelissen; M Mohty
Journal: Leukemia Date: 2014-05-20 Impact factor: 11.528

10. Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT.

Authors: R Martino; J L Piñana; R Parody; D Valcarcel; A Sureda; S Brunet; J Briones; J Delgado; F Sánchez; N Rabella; J Sierra
Journal: Bone Marrow Transplant Date: 2009-04-27 Impact factor: 5.483

1 in total

1. Allogeneic hematopoietic cell transplantation in patients ⩾70 years: which patients may benefit?

Authors: S P Haen; M Pham; C Faul; D Dörfel; W Vogel; L Kanz; W A Bethge
Journal: Blood Cancer J Date: 2016-07-08 Impact factor: 11.037

1 in total